US

Glympse Bio snags $22 mln Series A

Cambridge, Massachusetts-based Glympse Bio Inc, a provider of a platform that detects human diseases, has raised $22 million in Series A funding. LS Polaris Innovation Fund and ARCH Ventures led the round with participation from Charles River Ventures, Gilead Sciences, Yonghua Capital, Inevitable Ventures, GreatPoint Ventures, Heritage Provider Network and Rivas Capital.

Rgenix grabs $40 mln Series C

New York City-based Rgenix, Inc, a developer of first-in-class small molecule and antibody cancer therapeutics, has raised $40 million in Series C financing. Lepu Medical led the round with participation from other investors that included Oceanpine Capital, WuXi AppTec’s Corporate Venture Fund, Novo Holdings A/S, Sofinnova Partners, Alexandria Venture Investments LLC and the Partnership Fund for New York City’s Innovate NY Fund.

SystemOne fetches $5 mln Series A

Massachusetts and South Africa-based SystemOne, a provider of disease surveillance and response solutions, has raised $5 million in Series A funding. The Rise Fund, which is managed by TPG Growth, led the round with participation from other investors that included EchoVC and B&Y Venture Capital Partners. In conjunction with the funding, EchoVC’s Eghosa Omoigui has joined SystemOne’s board of directors.

German tech startup Pitch lands $19 mln Series A

Berlin-based Pitch, a tech startup, has raised $19 million in Series A funding. Index Ventures and BlueYard led the round. In addition to the funding, Neil Rimer, a partner at Index Ventures, has been added to Pitch's board.

Swiss brand management platform Frontify nets $8.3 mln Series A

Frontify, a Swiss brand management platform, has secured $8.3 million in Series A funding. Blossom Capital led the round.

Dragonfly to invest in cryptocurrencies with $100 mln maiden fund

San Francisco-based Dragonfly Capital Partners announced this morning its launch of a $100 million fund to invest in cryptocurrency deals. The firm is led by Managing Partners Alexander Pack, who previously headed network investing at Bain Capital Ventures, and Bo Feng, who previously was a founding partner of Ceyuan Ventures.The firm said it already has a portfolio of 20 companies, including Basis, Spacemesh and Oasis Labs. The fund's investors include Salil Deshpande of Bain Capital Ventures, Marc Andreessen and Chris Dixon of Andreessen Horowitz, Cyan Banister of Founders Fund, Olaf Carlson-Wee of Polychain Capital, Neil Shen of Sequoia China, and others.

Ex-NEA partner Jon Sakoda to raise $500 mln Catalyst Lab fund

Former New Enterprise Associates General Partner Jon Sakoda has filed to raise a $500 million venture-capital fund under the name Catalyst Labs Fund I, according to a filing with the SEC.

Forerunner raises larger $360 mln fourth venture fund

Forerunner Ventures said it raised a $360 million fourth fund to continuing investing in early-stage companies in a market place that has become increasingly competitive.

VC-based PhaseBio sets IPO pricing terms

PhaseBio Pharmaceuticals Inc, a developer of new treatments for orphan diseases, has priced its IPO Of 5 million shares between $12 and $14 per share. PhaseBio will trade the stock on the NASDAQ under the ticker symbol “PHAS.” Citigroup, Cowen and Stifel are the lead underwriters. PhaseBio's backers include Rock Springs Capital, Johnson & Johnson Innovation - JJDC, Mountain Group Capital, Cormorant Asset Management, Hatteras Venture Partners and New Enterprise Associates, according to Crunchbase.

Kitchen United snags $10 mln Series A in GV-led round

Virtual restaurant concept Kitchen United has secured $10 million in Series A funding. GV led the round.